Upregulation of suppressor of cytokine signaling 3 ameliorates spinal degenerative disease in adolescents by mediating leptin and tumor necrosis factor‑α levels

  • Authors:
    • Xiao‑Ming Tang
    • Jian Dai
    • Hai‑Lang Sun
  • View Affiliations

  • Published online on: July 17, 2019     https://doi.org/10.3892/etm.2019.7786
  • Pages: 2231-2237
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Spinal degenerative changes may occur following the rapid growth observed in adolescents, causing a reduced quality of life. The suppressor of cytokine signaling (SOCS) is involved in various degenerative diseases. The current study recruited adolescents with spinal degenerative disease (SDD) to identify the effect of SOCS‑3 on leptin and tumor necrosis factor‑α (TNF‑α) levels in this disorder. From January 2010 to January 2016, 120 adolescents (aged 14 to 25) were enrolled in the current study, with 68 diagnosed with SDD and the remaining 52 treated as controls. Nucleus pulposus cells (NPCs) were extracted and cultured in vitro. TNF‑α levels in NPCs were determined using flow cytometry. Degenerative NPCs were then transfected with pCR3.1‑SOCS‑3 and ELISA was performed to determined TNF‑α and leptin levels. RT‑qPCR was performed to measure the mRNA level of SOCS‑3 and leptin in NPCs and western blotting was utilized to detect the protein level of leptin and the extent of leptin receptor phosphorylation. The results revealed that TNF‑α levels in degenerative NPCs were higher than those in normal NPCs. The overexpression of SOCS‑3 reduced levels of TNF‑α and leptin in degenerative NPCs. In addition, the upregulation of leptin increased SOCS‑3 levels in a concentration‑dependent manner. Furthermore, the expression of the leptin receptor and phosphorylated leptin receptor gradually decreased with increasing leptin concentrations and the level of phosphorylated leptin receptor negatively correlated with SOCS‑3 expression. The inductive effect of leptin on the level of SOCS‑3 and the inhibitory effect of SOCS‑3 on the activity of leptin were identified. The current study demonstrated that SOCS‑3 reduces leptin and TNF‑α levels in degenerative NPCs from adolescents, indicating its potential role in the development of novel SDD therapies.

References

1 

Brinjikji W, Luetmer PH, Comstock B, Bresnahan BW, Chen LE, Deyo RA, Halabi S, Turner JA, Avins AL, James K, et al: Systematic literature review of imaging features of spinal degeneration in asymptomatic populations. AJNR Am J Neuroradiol. 36:811–816. 2015. View Article : Google Scholar : PubMed/NCBI

2 

Matsumoto M, Okada E, Ichihara D, Watanabe K, Chiba K, Toyama Y, Fujiwara H, Momoshima S, Nishiwaki Y, Hashimoto T, et al: Age-related changes of thoracic and cervical intervertebral discs in asymptomatic subjects. Spine (Phila Pa 1976). 35:1359–1364. 2010. View Article : Google Scholar : PubMed/NCBI

3 

Lao LF, Zhong GB, Li QY and Liu ZD: Kinetic magnetic resonance imaging analysis of spinal degeneration: A systematic review. Orthop Surg. 6:294–299. 2014. View Article : Google Scholar : PubMed/NCBI

4 

Goel A: Facet distraction spacers for treatment of degenerative disease of the spine: Rationale and an alternative hypothesis of spinal degeneration. J Craniovertebr Junction Spine. 1:65–66. 2010. View Article : Google Scholar : PubMed/NCBI

5 

Hey HW and Hee HT: Lumbar degenerative spinal deformity: Surgical options of PLIF, TLIF and MI-TLIF. Indian J Orthop. 44:159–162. 2010. View Article : Google Scholar : PubMed/NCBI

6 

Takatalo J, Karppinen J, Näyhä S, Taimela S, Niinimäki J, Blanco Sequeiros R, Tammelin T, Auvinen J and Tervonen O: Association between adolescent sport activities and lumbar disk degeneration among young adults. Scand J Med Sci Sports. 27:1993–2001. 2017. View Article : Google Scholar : PubMed/NCBI

7 

Wang H, Cheng J, Xiao H, Li C and Zhou Y: Adolescent lumbar disc herniation: Experience from a large minimally invasive treatment centre for lumbar degenerative disease in Chongqing, China. Clin Neurol Neurosurg. 115:1415–1419. 2013. View Article : Google Scholar : PubMed/NCBI

8 

Daniels DJ, Luo TD, Puffer R, McIntosh AL, Larson AN, Wetjen NM and Clarke MJ: Degenerative changes in adolescent spines: A comparison of motocross racers and age-matched controls. J Neurosurg Pediatr. 15:266–271. 2015. View Article : Google Scholar : PubMed/NCBI

9 

Omair A, Holden M, Lie BA, Reikeras O and Brox JI: Treatment outcome of chronic low back pain and radiographic lumbar disc degeneration are associated with inflammatory and matrix degrading gene variants: A prospective genetic association study. BMC Musculoskelet Disord. 14:1052013. View Article : Google Scholar : PubMed/NCBI

10 

Ren Y and Young W: Managing inflammation after spinal cord injury through manipulation of macrophage function. Neural Plast. 2013:9450342013. View Article : Google Scholar : PubMed/NCBI

11 

Carow B and Rottenberg ME: SOCS3, a Major regulator of infection and inflammation. Front Immunol. 5:582014. View Article : Google Scholar : PubMed/NCBI

12 

Park KW, Lin CY and Lee YS: Expression of suppressor of cytokine signaling-3 (SOCS3) and its role in neuronal death after complete spinal cord injury. Exp Neurol. 261:65–75. 2014. View Article : Google Scholar : PubMed/NCBI

13 

Park KW, Lin CY, Li K and Lee YS: Effects of reducing suppressors of cytokine signaling-3 (SOCS3) expression on dendritic outgrowth and demyelination after spinal cord injury. PLoS One. 10:e01383012015. View Article : Google Scholar : PubMed/NCBI

14 

Osuka K, Usuda N, Aoyama M, Yamahata H, Takeuchi M, Yasuda M and Takayasu M: Expression of the JAK/STAT3/SOCS3 signaling pathway in herniated lumbar discs. Neurosci Lett. 569:55–58. 2014. View Article : Google Scholar : PubMed/NCBI

15 

Gui T, He BS, Gan Q and Yang C: Enhanced SOCS3 in osteoarthiritis may limit both proliferation and inflammation. Biotech Histochem. 92:107–114. 2017. View Article : Google Scholar : PubMed/NCBI

16 

Dreier R: Hypertrophic differentiation of chondrocytes in osteoarthritis: The developmental aspect of degenerative joint disorders. Arthritis Res Ther. 12:2162010. View Article : Google Scholar : PubMed/NCBI

17 

Babon JJ and Nicola NA: The biology and mechanism of action of suppressor of cytokine signaling 3. Growth Factors. 30:207–219. 2012. View Article : Google Scholar : PubMed/NCBI

18 

Lubis AR, Widia F, Soegondo S and Setiawati A: The role of SOCS-3 protein in leptin resistance and obesity. Acta Med Indones. 40:89–95. 2008.PubMed/NCBI

19 

Garner M, Alshameeri Z and Khanduja V: Osteoarthritis: Genes, nature-nurture interaction and the role of leptin. Int Orthop. 37:2499–2505. 2013. View Article : Google Scholar : PubMed/NCBI

20 

Vuolteenaho K, Koskinen A and Moilanen E: Leptin-a link between obesity and osteoarthritis. Applications for prevention and treatment. Basic Clin Pharmacol Toxicol. 114:103–108. 2014. View Article : Google Scholar : PubMed/NCBI

21 

Mutabaruka MS, Aoulad Aissa M, Delalandre A, Lavigne M and Lajeunesse D: Local leptin production in osteoarthritis subchondral osteoblasts may be responsible for their abnormal phenotypic expression. Arthritis Res Ther. 12:R202010. View Article : Google Scholar : PubMed/NCBI

22 

Johnson ZI, Schoepflin ZR, Choi H, Shapiro IM and Risbud MV: Disc in flames: Roles of TNF-alpha and IL-1β in intervertebral disc degeneration. Eur Cell Mater. 30:104–116. 2015. View Article : Google Scholar : PubMed/NCBI

23 

Collins AS, Ahmed S, Napoletano S, Schroeder M, Johnston JA, Hegarty JE, O'Farrelly C and Stevenson NJ: Hepatitis C virus (HCV)-induced suppressor of cytokine signaling (SOCS) 3 regulates proinflammatory TNF-α responses. J Leukoc Biol. 96:255–263. 2014. View Article : Google Scholar : PubMed/NCBI

24 

Poiraudeau S, Monteiro I, Anract P, Blanchard O, Revel M and Corvol MT: Phenotypic characteristics of rabbit intervertebral disc cells. Comparison with cartilage cells from the same animals. Spine (Phila Pa 1976). 24:837–844. 1999. View Article : Google Scholar : PubMed/NCBI

25 

Chelberg MK, Banks GM, Geiger DF and Oegema TR Jr: Identification of heterogeneous cell populations in normal human intervertebral disc. J Anat. 186:43–53. 1995.PubMed/NCBI

26 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

27 

Yu J, Ryan DG, Getsios S, Oliveira-Fernandes M, Fatima A and Lavker RM: MicroRNA-184 antagonizes microRNA-205 to maintain SHIP2 levels in epithelia. Proc Natl Acad Sci USA. 105:19300–19305. 2008. View Article : Google Scholar : PubMed/NCBI

28 

Yu J, Peng H, Ruan Q, Fatima A, Getsios S and Lavker RM: MicroRNA-205 promotes keratinocyte migration via the lipid phosphatase SHIP2. FASEB J. 24:3950–3959. 2010. View Article : Google Scholar : PubMed/NCBI

29 

Kumar R, Kumar V, Das NK, Behari S and Mahapatra AK: Adolescent lumbar disc disease: Findings and outcome. Childs Nerv Syst. 23:1295–1299. 2007. View Article : Google Scholar : PubMed/NCBI

30 

Lindemann C, Hackmann O, Delic S, Schmidt N, Reifenberger G and Riemenschneider MJ: SOCS3 promoter methylation is mutually exclusive to EGFR amplification in gliomas and promotes glioma cell invasion through STAT3 and FAK activation. Acta Neuropathol. 122:241–251. 2011. View Article : Google Scholar : PubMed/NCBI

31 

Kershaw NJ, Murphy JM, Liau NP, Varghese LN, Laktyushin A, Whitlock EL, Lucet IS, Nicola NA and Babon JJ: SOCS3 binds specific receptor-JAK complexes to control cytokine signaling by direct kinase inhibition. Nat Struct Mol Biol. 20:469–476. 2013. View Article : Google Scholar : PubMed/NCBI

32 

Dai Z, Lu L, Yang Z, Mao Y, Lu J, Li C, Qi W, Chen Y, Yao Y, Li L, et al: Kallikrein-binding protein inhibits LPS-induced TNF-α by upregulating SOCS3 expression. J Cell Biochem. 114:1020–1028. 2013. View Article : Google Scholar : PubMed/NCBI

33 

Collino M, Benetti E, Miglio G, Castiglia S, Rosa AC, Aragno M, Thiemermann C and Fantozzi R: Peroxisome proliferator-activated receptor β/δ agonism protects the kidney against ischemia/reperfusion injury in diabetic rats. Free Radic Biol Med. 50:345–353. 2011. View Article : Google Scholar : PubMed/NCBI

34 

Ohtori S, Inoue G, Eguchi Y, Orita S, Takaso M, Ochiai N, Kishida S, Kuniyoshi K, Aoki Y, Nakamura J, et al: Tumor necrosis factor-α-immunoreactive cells in nucleus pulposus in adolescent patients with lumbar disc herniation. Spine (Phila Pa 1976). 38:459–462. 2013. View Article : Google Scholar : PubMed/NCBI

35 

Kang R, Li H, Rickers K, Ringgaard S, Xie L and Bünger C: Intervertebral disc degenerative changes after intradiscal injection of TNF-α in a porcine model. Eur Spine J. 24:2010–2016. 2015. View Article : Google Scholar : PubMed/NCBI

36 

Wang L, Tang X, Zhang H, Yuan J, Ding H and Wei Y: Elevated leptin expression in rat model of traumatic spinal cord injury and femoral fracture. J Spinal Cord Med. 34:501–509. 2011. View Article : Google Scholar : PubMed/NCBI

37 

Vuolteenaho K, Koskinen A, Moilanen T and Moilanen E: Leptin levels are increased and its negative regulators, SOCS-3 and sOb-R are decreased in obese patients with osteoarthritis: A link between obesity and osteoarthritis. Ann Rheum Dis. 71:1912–1913. 2012. View Article : Google Scholar : PubMed/NCBI

38 

Yang Z, Hulver M, McMillan RP, Cai L, Kershaw EE, Yu L, Xue B and Shi H: Regulation of insulin and leptin signaling by muscle suppressor of cytokine signaling 3 (SOCS3). PLoS One. 7:e474932012. View Article : Google Scholar : PubMed/NCBI

39 

Teran-Cabanillas E and Hernandez J: Role of Leptin and SOCS3 in inhibiting the type I interferon response during obesity. Inflammation. 40:58–67. 2017. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

September 2019
Volume 18 Issue 3

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Tang, X., Dai, J., & Sun, H. (2019). Upregulation of suppressor of cytokine signaling 3 ameliorates spinal degenerative disease in adolescents by mediating leptin and tumor necrosis factor‑α levels. Experimental and Therapeutic Medicine, 18, 2231-2237. https://doi.org/10.3892/etm.2019.7786
MLA
Tang, X., Dai, J., Sun, H."Upregulation of suppressor of cytokine signaling 3 ameliorates spinal degenerative disease in adolescents by mediating leptin and tumor necrosis factor‑α levels". Experimental and Therapeutic Medicine 18.3 (2019): 2231-2237.
Chicago
Tang, X., Dai, J., Sun, H."Upregulation of suppressor of cytokine signaling 3 ameliorates spinal degenerative disease in adolescents by mediating leptin and tumor necrosis factor‑α levels". Experimental and Therapeutic Medicine 18, no. 3 (2019): 2231-2237. https://doi.org/10.3892/etm.2019.7786